VRS
Virginia Retirement Systems Portfolio holdings
AUM
$14.5B
This Quarter Return
+9.44%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$10.2B
AUM Growth
-$68.7M
(-0.67%)
Cap. Flow
-$895M
Cap. Flow
% of AUM
-8.81%
Top 10 Holdings %
Top 10 Hldgs %
21.74%
Holding
1,189
New
92
Increased
348
Reduced
531
Closed
178
Top Buys
| 1 |
Northern Trust
NTRS
|
$35.7M |
| 2 |
Allstate
ALL
|
$31.7M |
| 3 |
Ameren
AEE
|
$29.6M |
| 4 |
Exelon
EXC
|
$27M |
| 5 |
CBRE Group
CBRE
|
$26.5M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$69.3M |
| 2 |
Ziff Davis
ZD
|
$45.3M |
| 3 |
NextEra Energy, Inc.
NEE
|
$43.2M |
| 4 |
Alibaba
BABA
|
$41.5M |
| 5 |
Entergy
ETR
|
$34M |
Sector Composition
| 1 | Technology | 21.83% |
| 2 | Financials | 14.96% |
| 3 | Healthcare | 11.74% |
| 4 | Real Estate | 10.49% |
| 5 | Communication Services | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
Dolby
DLB
$6.96B
| $256K | ﹤0.01% |
2,600
+200
| +8% | +$19.7K |
|
952
Boot Barn
BOOT
$5.58B
| $252K | ﹤0.01% |
+3,000
| New | +$252K |
|
953
Coeur Mining
CDE
$9.43B
| $252K | ﹤0.01% |
28,400
-4,900
| -15% | -$43.5K |
|
954
Eagle Bancorp
EGBN
$602M
| $252K | ﹤0.01% |
4,500
-100
| -2% | -$5.6K |
|
955
BellRing Brands
BRBR
$4.97B
| $251K | ﹤0.01% |
+8,000
| New | +$251K |
|
956
E.W. Scripps
SSP
$261M
| $251K | ﹤0.01% |
+12,300
| New | +$251K |
|
957
First Financial Bancorp
FFBC
$2.5B
| $250K | ﹤0.01% |
10,600
-13,700
| -56% | -$323K |
|
958
Atara Biotherapeutics
ATRA
$90.7M
| $249K | ﹤0.01% |
+640
| New | +$249K |
|
959
Fox Factory Holding Corp
FOXF
$1.22B
| $249K | ﹤0.01% |
+1,600
| New | +$249K |
|
960
Immunovant
IMVT
$2.99B
| $249K | ﹤0.01% |
23,600
-3,300
| -12% | -$34.8K |
|
961
Stifel
SF
$11.5B
| $246K | ﹤0.01% |
3,800
-800
| -17% | -$51.8K |
|
962
Karyopharm Therapeutics
KPTI
$57.2M
| $243K | ﹤0.01% |
+1,567
| New | +$243K |
|
|
KAMN
963
DELISTED
Kaman Corp
KAMN
| $242K | ﹤0.01% |
4,800
-3,800
| -44% | -$192K |
|
964
Regenxbio
RGNX
$490M
| $237K | ﹤0.01% |
+6,100
| New | +$237K |
|
|
TECX
965
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $237K | ﹤0.01% |
2,225
+667
| +43% | +$71K |
|
|
DBD
966
DELISTED
Diebold Nixdorf Incorporated
DBD
| $236K | ﹤0.01% |
18,400
+2,900
| +19% | +$37.2K |
|
967
Sonoco
SON
$4.56B
| $234K | ﹤0.01% |
3,500
+100
| +3% | +$6.69K |
|
968
John B. Sanfilippo & Son
JBSS
$749M
| $230K | ﹤0.01% |
2,600
+100
| +4% | +$8.85K |
|
969
Enovis
ENOV
$1.84B
| $229K | ﹤0.01% |
2,905
-33,233
| -92% | -$2.62M |
|
|
ENLC
970
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $229K | ﹤0.01% |
+35,800
| New | +$229K |
|
|
VRAY
971
DELISTED
ViewRay, Inc.
VRAY
| $228K | ﹤0.01% |
34,600
+3,900
| +13% | +$25.7K |
|
|
TCRR
972
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $228K | ﹤0.01% |
13,900
+3,700
| +36% | +$60.7K |
|
973
Methode Electronics
MEI
$250M
| $226K | ﹤0.01% |
4,600
-2,300
| -33% | -$113K |
|
974
Tenable Holdings
TENB
$3.76B
| $223K | ﹤0.01% |
+5,400
| New | +$223K |
|
975
Ennis
EBF
$476M
| $222K | ﹤0.01% |
10,300
-400
| -4% | -$8.62K |
|